EZH2 and metastatic malignant neoplasm in the lymph nodes: Clinical and preclinical studies showed an inverse correlation between EZH2 expression and E-cadherin in PDAC [63], where high EZH2 expression was associated with advanced disease stage and lymph node metastasis [64].